Craig Peters, DO
Cardiovascular Disease · Flagstaff, AZNPI 1023167384
Payments from drug & device makers
Across 55 payments — averaging $86.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$2K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$896
- Impulse Dynamics (USA) Inc.$428
- Edwards Lifesciences$360
- Boston Scientific$334
- Abiomed$288
- plus $855 from 5 others
What the payments were for
- Food & beverage$4,770100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 13 | $1,610 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 21 | $896 |
| Impulse Dynamics (USA) Inc. | 3 | $428 |
| Edwards Lifesciences | 2 | $360 |
| Boston Scientific | 4 | $334 |
| Abiomed | 3 | $288 |
| Bayer | 2 | $243 |
| Amgen | 3 | $236 |
| Kestra Medical Technology Services, Inc. | 2 | $176 |
| Medtronic | 1 | $152 |
| ZOLL Circulation Inc | 1 | $48 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AVEIR$745
- OPTIMIZER$739
- GALLANT$441
- LifeVest$384
- Watchman$326
- Edwards SAPIEN 3 Transcatheter Heart Valve$198
- SAPIEN 3 Ultra RESILIA$161
- Assure WCD$156
- ASSURITY$155
- Micra$152
- Kerendia$148
- Assurity Pacemaker$141
- Impella$127
- Repatha$124
How this compares
$4,770 in reported general payments places this provider in the 60th percentile of 423 cardiovascular disease providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 379 | $360,322 |
| Repatha SureclickEvolocumab | 98 | $86,340 |
| XareltoRivaroxaban | 62 | $54,853 |
| JardianceEmpagliflozin | 67 | $53,312 |
| EntrestoSacubitril/Valsartan | 49 | $50,278 |
| BrilintaTicagrelor | 16 | $12,014 |
| MultaqDronedarone Hcl | 12 | $9,513 |
| FarxigaDapagliflozin Propanediol | 13 | $7,103 |
| Atorvastatin Calcium | 576 | $5,591 |
| Ezetimibe | 168 | $4,995 |
| Metoprolol Succinate | 342 | $3,725 |
| Ranolazine ErRanolazine | 33 | $3,410 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 37 | $2,640 |
| Losartan Potassium | 280 | $2,560 |
| Flecainide Acetate | 58 | $2,091 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Flagstaff
- Omar WaniFlagstaff$295K
- Christopher MuellerFlagstaff$105K
- David RizikScottsdale$2.1M
- Rodrigo ChanMesa$2M
- Ashish GuptaPhoenix$1.2M
- Rajkumar SugumaranPhoenix$957K
- Krishnaswami VijayaraghavanScottsdale$927K
- Gregory KoshkarianTucson$608K
- Andrew KaplanMesa$455K
- Charles JostMesa$374K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.